XESX:LSE:LSE-Xtrackers Euro Stoxx 50 UCITS ETF 1D (GBX)

ETF | Others |

Last Closing

USD 4634.75

Change

+37.50 (+0.82)%

Market Cap

N/A

Volume

2.83K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+4.67 (+3.61%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.03 (+0.15%)

USD 588.35B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.32%)

USD 588.35B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.70 (+1.10%)

USD 266.08B
0QZO:LSE 0QZO

-1.90 (-1.71%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.07 (+0.22%)

USD 244.75B
0QZ3:LSE Qualcomm Inc.

+1.16 (+0.69%)

USD 202.26B
0R24:LSE Intel Corp.

+0.63 (+3.28%)

USD 196.14B

ETFs Containing XESX:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.20% 91% A- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.20% 91% A- 85% B
Trailing 12 Months  
Capital Gain 10.05% 49% F 55% F
Dividend Return 0.03% 22% F 19% F
Total Return 10.08% 47% F 53% F
Trailing 5 Years  
Capital Gain 35.08% 57% F 67% D+
Dividend Return 0.17% 30% F 43% F
Total Return 35.26% 55% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 9.98% 61% D- 66% D+
Dividend Return 10.00% 60% D- 65% D
Total Return 0.02% 27% F 19% F
Risk Return Profile  
Volatility (Standard Deviation) 13.49% 53% F 70% C-
Risk Adjusted Return 74.09% 72% C 83% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.